| SC 13G/A | 2021-02-16 | SPHERA FUNDS MANAGEMENT LTD. | Neos Therapeutics, Inc. | - | 0.0% | EDGAR |
| SC 13G/A | 2021-02-12 | GOLDMAN SACHS & CO. LLC | Neos Therapeutics, Inc. | 337,247 | 0.7% | EDGAR |
| SC 13G/A | 2021-02-12 | Stonepine Capital Management, LLC | Neos Therapeutics, Inc. | 4,962,657 | 10.0% | EDGAR |
| SC 13G/A | 2021-02-12 | Nantahala Capital Management, LLC | Neos Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2020-02-14 | Broadfin Capital, LLC | Neos Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2020-02-13 | Stonepine Capital Management, LLC | Neos Therapeutics, Inc. | 4,858,889 | 9.8% | EDGAR |
| SC 13G/A | 2020-02-13 | Nantahala Capital Management, LLC | Neos Therapeutics, Inc. | 4,610,000 | 9.3% | EDGAR |
| SC 13G/A | 2020-02-11 | SPHERA FUNDS MANAGEMENT LTD. | Neos Therapeutics, Inc. | 3,530,731 | 7.1% | EDGAR |
| SC 13G | 2020-01-31 | GOLDMAN SACHS GROUP INC | Neos Therapeutics, Inc. | 2,548,749 | 5.1% | EDGAR |
| SC 13G/A | 2019-07-10 | BlackRock Inc. | Neos Therapeutics, Inc. | 530,249 | 1.1% | EDGAR |
| SC 13G | 2019-07-02 | SPHERA FUNDS MANAGEMENT LTD. | Neos Therapeutics, Inc. | 3,711,454 | 7.5% | EDGAR |
| SC 13G | 2019-02-14 | Nantahala Capital Management, LLC | Neos Therapeutics, Inc. | 4,485,000 | 9.0% | EDGAR |
| SC 13G/A | 2019-02-13 | Stonepine Capital Management, LLC | Neos Therapeutics, Inc. | 4,210,153 | 8.5% | EDGAR |
| SC 13G | 2019-02-08 | BlackRock Inc. | Neos Therapeutics, Inc. | 2,733,411 | 5.5% | EDGAR |
| SC 13G/A | 2019-01-28 | FRANKLIN RESOURCES INC | Neos Therapeutics, Inc. | 2,030,204 | 4.1% | EDGAR |
| SC 13G | 2019-01-03 | Broadfin Capital, LLC | Neos Therapeutics, Inc. | 2,618,819 | 5.3% | EDGAR |
| SC 13G/A | 2018-12-07 | BlackRock Inc. | Neos Therapeutics, Inc. | 2,104,146 | 4.5% | EDGAR |
| SC 13G/A | 2018-11-30 | Flynn James E | Neos Therapeutics, Inc. | 1,676,567 | 3.3% | EDGAR |
| SC 13G | 2018-11-08 | Stonepine Capital Management, LLC | Neos Therapeutics, Inc. | 4,637,169 | 9.3% | EDGAR |
| SC 13G | 2018-11-08 | Flynn James E | Neos Therapeutics, Inc. | 2,352,512 | 4.9% | EDGAR |